|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-2.76/--
|
企業價值
35.20M
|
資產負債 |
每股賬面淨值
1.29
|
現金流量 |
現金流量率
--
|
損益表 |
收益
--
|
每股收益
--
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|

同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for the treatment of cardiac arrhythmias. The company focuses on developing cryoablation technologies that create contiguous, transmural lesions to treat cardiacarrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia. |